| 标题 |
Lecanemab, Aducanumab, and Gantenerumab — Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease |
| 网址 | |
| DOI | |
| 其它 |
期刊:Neurotherapeutics 作者:Linda Söderberg; Malin Johannesson; Patrik Nygren; Hanna Laudon; Fredrik Eriksson; et al 出版日期:2022-10-17 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)